Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results deaths Eclinical improvement Edeath or ventilation E

COVID 19 outpatients meta-analysis

Cov-2069 (Cohort B: positive SARS-CoV-2 RT-qPCR test result), 2021
RCTcasirivimab/imdevimab (Ronapreve)placeboCOVID 19 outpatientssome concern
156/158 conclusif 1%
Cov-2067 Weinreich (1200mg) Cohort 1, 2020
RCTcasirivimab/imdevimab (Ronapreve)placeboCOVID 19 outpatientssome concern
838/840 conclusif -50%

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).